REGULATORY

• LDP Members Fret over Easier Access to Abortion Pill Mefeego
  July 29, 2024

• Off-Year Revision Debate to Follow Honebuto Policy: MHLW Bureau Chief
  July 29, 2024

• MHLW Plans Disposal of COVID-19 Antibody Meds in Government Stock
  July 26, 2024

• HeartSheet’s Conditional Approval to Be Withdrawn as Early as August
  July 26, 2024

• LDP Policy Panel OKs FY2025 Budget Guidelines, Lower Cap Likely for “Natural Increase”
  July 24, 2024

• Health Minister Hopes to Tap US Insights to Foster Japan Ecosystem
  July 24, 2024

• MHLW Seeks Input to Gird for Summer Outbreaks, FPMAJ Ready to Ask for Ramp-Up
  July 23, 2024

• Japan’s Fall-Winter COVID Vaccinations Likely to Start from October
  July 23, 2024

• MHLW Panel to Review Takeda’s Fruzaqla on Aug. 2; Truvada, Keytruda, Prevenar 20 on Roster Too
  July 22, 2024

• MHLW Sets Exceptions to All-Case PMS through Revised Q&A
  July 22, 2024

• Japan Panel Says No to Full Approval of HeartSheet, Clears Breyanzi’s Broader Label
  July 22, 2024

• Japan Panel Discusses Details of NIP for Shingles Jabs, OKs Inclusion of Prevenar 20
  July 19, 2024

• Lilly’s Alzheimer’s Med Up for Health Ministry Panel Review on August 1
  July 19, 2024

• MHLW Pharma Management Director Hints at Addressing “Zero” Premium Issue
  July 19, 2024

• Chuikyo OKs Plan for Drug Price Survey in FY2024
  July 18, 2024

• Debates on FY2025 Off-Year Price Revision Officially Set Sail at Chuikyo
  July 18, 2024

• Label Revisions Ordered for Opdivo, Yervoy, Duvroq, and More
  July 18, 2024

• LDP Lawmakers Call for Expanded Budget for Pharma Innovation, Stable Supplies
  July 18, 2024

• MHLW Clarifies Criteria for “Medical Necessity” of LLPs before Elective Care Rollout
  July 17, 2024

• Pharma Innovation, Supply Raised as Key Topics for FY2025 Budget: LDP Confab
  July 10, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 43
• 44
• 45
• 46
• 47
• 48
• 49
• 50
• 51
• …
• Next ›
• 最終 »